| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1203475417745827 |
| P698 | PubMed publication ID | 29191054 |
| P2093 | author name string | Aditya K Gupta | |
| Neil H Shear | |||
| Jessie Carviel | |||
| P2860 | cites work | Fitness and its role in evolutionary genetics | Q22122004 |
| Human dectin-1 deficiency and mucocutaneous fungal infections | Q24645008 | ||
| Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species | Q26748172 | ||
| Antifungal Th Immunity: Growing up in Family | Q27002920 | ||
| Onychomycosis: Practical Approaches to Minimize Relapse and Recurrence | Q28073085 | ||
| IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis | Q28534626 | ||
| Allergy and dermatophytes | Q30435661 | ||
| STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis | Q34196284 | ||
| Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi | Q35277854 | ||
| The damage-response framework of microbial pathogenesis | Q35709086 | ||
| Nail changes and disorders among the elderly | Q36361163 | ||
| Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism | Q36413916 | ||
| IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi | Q37129200 | ||
| Role of HLA-DR Alleles to Increase Genetic Susceptibility to Onychomycosis in Nail Psoriasis. | Q37394677 | ||
| Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency | Q37534176 | ||
| Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. | Q37712848 | ||
| Toenail onychomycosis: an important global disease burden | Q37787316 | ||
| Insights into human antifungal immunity from primary immunodeficiencies. | Q37940665 | ||
| The impact of the host on fungal infections | Q37971087 | ||
| Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects | Q37979503 | ||
| Do genetic mutations and genotypes contribute to onychomycosis? | Q38200864 | ||
| Binding of DC-HIL to dermatophytic fungi induces tyrosine phosphorylation and potentiates antigen presenting cell function | Q38350006 | ||
| Immunoresponses in dermatomycoses | Q38367351 | ||
| IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections through Induction of IL-13 Production by CD4+ T Cells | Q38427252 | ||
| Immunoregulation of dermatophytosis | Q38618458 | ||
| The role of biofilms in onychomycosis | Q38787982 | ||
| Human pathogenic fungus Trichophyton schoenleinii activates the NLRP3 inflammasome | Q39149892 | ||
| Cytokine secretion profiles of human keratinocytes during Trichophyton tonsurans and Arthroderma benhamiae infections | Q40242668 | ||
| Endogenous antimicrobial peptides and skin infections in atopic dermatitis | Q40698186 | ||
| New insights into genes, immunity, and the occurrence of dermatophytosis. | Q41493357 | ||
| Low DEFB4 copy number and high systemic hBD-2 and IL-22 levels are associated with dermatophytosis | Q41759033 | ||
| Microbe driven T-helper cell differentiation: lessons from Candida albicans and Staphylococcus aureus. | Q42205449 | ||
| Candida albicans dampens host defense by downregulating IL-17 production. | Q42972455 | ||
| Familial chronic nail candidiasis with ICAM-1 deficiency: a new form of chronic mucocutaneous candidiasis | Q43074573 | ||
| Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. | Q43239054 | ||
| Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi. | Q43733156 | ||
| HLA-associated susceptibility to chronic onychomycosis in Brazilian Ashkenazic Jews | Q43774864 | ||
| Analysis of genetic polymorphism of the HLA-B and HLA-DR loci in patients with dermatophytic onychomycosis and in their first-degree relatives | Q44042203 | ||
| Genomic studies of disease-outcome in host--pathogen dynamics | Q44855793 | ||
| Patient-Reported Outcomes in Onychomycosis: A Review of Psychometrically Evaluated Instruments in Assessing Treatment Effectiveness. | Q47961761 | ||
| Effect of onychomycosis on quality of life. | Q50887968 | ||
| CD4+CD25+ Treg cells in patients with toenail onychomycosis. | Q51763760 | ||
| HLA‐DR6 association confers increased resistance to T. rubrum onychomycosis in Mexican Mestizos | Q54401113 | ||
| Sensing of mammalian IL-17A regulates fungal adaptation and virulence. | Q54528212 | ||
| NKp30 enables NK cells to act naturally with fungi. | Q54729824 | ||
| Immunity to fungal infections | Q58855371 | ||
| P304 | page(s) | 1203475417745827 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Journal of cutaneous medicine and surgery | Q25380090 |
| P1476 | title | Onychomycosis and Chronic Fungal Disease: Exploiting a Commensal Disguise to Stage a Covert Invasion |
| Q93126474 | A Week of Oral Terbinafine Pulse Regimen Every Three Months to Treat all Dermatophyte Onychomycosis | cites work | P2860 |
Search more.